|
Market Closed -
Nasdaq
01:00:00 13/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 16.51 USD | -7.30% |
|
+6.58% | -45.82% |
| 10-28 | Beta Bionics, Inc., Q3 2026 Earnings Call, Oct 27, 2026 | |
| 10-28 | Earnings Flash (BBNX) Beta Bionics Posts Q3 Per-Share Loss $0.52, vs. FactSet Est of $0.52 Loss | MT |
Company Valuation: Beta Bionics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 1,341 | 897.6 | - | - |
| Change | - | -33.09% | - | - |
| Enterprise Value (EV) 1 | 1,130 | 678.8 | 795.1 | 838.7 |
| Change | - | -39.9% | 17.13% | 5.48% |
| P/E | -16.8x | -8.06x | -7.77x | -10.6x |
| PBR | 4.7x | 2.34x | 2.95x | 3.22x |
| PEG | 0.2x | -0.6x | -2.08x | 0.4x |
| Capitalization / Revenue | 13.4x | 7.15x | 4.86x | 3.12x |
| EV / Revenue | 11.3x | 5.41x | 4.31x | 2.92x |
| EV / EBITDA | -21.4x | -8.88x | -9.37x | -17.3x |
| EV / EBIT | -15.8x | -6.39x | -6.44x | -8.6x |
| EV / FCF | -20.1x | -7.33x | -6.64x | -12.6x |
| FCF Yield | -4.98% | -13.6% | -15.1% | -7.95% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -1.81 | -2.049 | -2.126 | -1.556 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 100.3 | 125.5 | 184.7 | 287.3 |
| EBITDA 1 | -52.75 | -76.47 | -84.83 | -48.57 |
| EBIT 1 | -71.68 | -106.2 | -123.5 | -97.51 |
| Net income 1 | -73.2 | -96.76 | -113.5 | -82.11 |
| Net Debt 1 | -211.9 | -218.8 | -102.5 | -58.95 |
| Reference price 2 | 30.47 | 16.51 | 16.51 | 16.51 |
| Nbr of stocks (in thousands) | 44,025 | 54,367 | - | - |
| Announcement Date | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.06x | 5.41x | -8.88x | -.--% | 898M | |
| 35.81x | 6.1x | 23.32x | 0.27% | 259B | |
| 36.91x | 7x | 21.93x | 0.62% | 163B | |
| 50.87x | 12.28x | 26.36x | -.--% | 152B | |
| 18.05x | 3.56x | 11.58x | -.--% | 64.07B | |
| 44.83x | 8.42x | 26.56x | -.--% | 60.84B | |
| 21.45x | 2.55x | 12.88x | 2.35% | 53.91B | |
| 33.71x | 6.68x | 22.69x | 0.59% | 48.78B | |
| 46.29x | 11.35x | 25.02x | -.--% | 48.96B | |
| 133.83x | 7.63x | 23.18x | -.--% | 45.43B | |
| Average | 41.37x | 7.10x | 18.46x | 0.38% | 90B | |
| Weighted average by Cap. | 42.42x | 7.47x | 22.36x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BBNX Stock
- Valuation Beta Bionics, Inc.
Select your edition
All financial news and data tailored to specific country editions
